Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-29
2005-03-29
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S309000, C544S310000, C544S314000, C544S311000
Reexamination Certificate
active
06872728
ABSTRACT:
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:wherein A, Q, R1, R2, R3a, R3b, R4, R5, R6and n are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
REFERENCES:
patent: 4950670 (1990-08-01), Frost et al.
patent: 5140029 (1992-08-01), Kennis et al.
patent: 5476855 (1995-12-01), el Kouni et al.
patent: 5744479 (1998-04-01), Furuya et al.
patent: 5780437 (1998-07-01), Goulet et al.
patent: 5849764 (1998-12-01), Goulet et al.
patent: 5859014 (1999-01-01), Bantle et al.
patent: 6232318 (2001-05-01), Nerenberg et al.
patent: 6608197 (2003-08-01), Zhu et al.
patent: 0 748 800 (1996-12-01), None
patent: 1 004 585 (2000-05-01), None
patent: WO 9624597 (1996-08-01), None
patent: WO 9638438 (1996-12-01), None
patent: WO 9714682 (1997-04-01), None
patent: WO 9714697 (1997-04-01), None
patent: WO 9721435 (1997-06-01), None
patent: WO 9721703 (1997-06-01), None
patent: WO 9721704 (1997-06-01), None
patent: WO 9721707 (1997-06-01), None
patent: WO 9744037 (1997-11-01), None
patent: WO 9744041 (1997-11-01), None
patent: WO 9744321 (1997-11-01), None
patent: WO 9744339 (1997-11-01), None
patent: WO 9855116 (1998-12-01), None
patent: WO 9855119 (1998-12-01), None
patent: WO 9855470 (1998-12-01), None
patent: WO 9855479 (1998-12-01), None
patent: WO 9909033 (1999-02-01), None
patent: WO 9933831 (1999-07-01), None
patent: WO 9951232 (1999-10-01), None
patent: WO 0029386 (2000-05-01), None
patent: WO 0069833 (2000-11-01), None
patent: WO 0069859 (2000-11-01), None
patent: WO 0129044 (2001-04-01), None
Cho et al., “Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor,”J. Med. Chem. 41(22):4190-4195, 1998.
Koerber et al., “Consensus Bioactive Conformation of Cyclic GnRH Antagonists Defined by NMR and Molecular Modeling,”J. Med. Chem. 43(5):819-828, 2000.
Huirn and Lambalk, “Gonadotropin-releasing-hormone-receptor antagonists,”Lancet358(9295):1793-1803, 2001.
Chen Chen
Gross Timothy D.
Guo Zhiqiang
Rowbottom Martin
Struthers R. Scott
Balasubramanian Venkataraman
Neurocrine Biosciences Inc.
Seed IP Law Group PLLC
LandOfFree
Gonadotropin-releasing hormone receptor antagonists and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gonadotropin-releasing hormone receptor antagonists and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gonadotropin-releasing hormone receptor antagonists and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3384793